(Q31817214)

4 July 2017

title

Lipoprotein (a) as a predictor of myocardial infarction in middle-aged men. (English)

1 reference

4 July 2017

1 reference

myocardial infarction

1 reference

M Seed

1

1 reference

4 July 2017

K L Ayres

series ordinal

2

1 reference

4 July 2017

S E Humphries

series ordinal

3

1 reference

4 July 2017

G J Miller

series ordinal

4

1 reference

4 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

American Journal of Medicine

4 July 2017

published in

1 reference

4 July 2017

volume

110

1 reference

4 July 2017

issue

1

1 reference

4 July 2017

page(s)

22-27

1 reference

Myocardial ischaemia, risk factors and death from coronary heart-disease

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

Apolipoproteins and ischaemic heart disease: implications for screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

Lipoprotein(a) and Atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

Thrombogenesis linked to atherogenesis at last?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

A potential basis for the thrombotic risks associated with lipoprotein(a).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

Antifibrinolytic activity of apolipoprotein(a) in vivo: Human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

Catabolism of lipoprotein(a) in familial hypercholesterolaemic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

The mysteries of lipoprotein(a)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

Is lipoprotein(a)-cholesterol a better predictor of vascular disease events than total lipoprotein(a) mass? A nested case control study from the West of Scotland Coronary Prevention Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

A prospective study of lipoprotein(a) and the risk of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

Lipoprotein(a) in stored plasma samples and the ravages of time. Why epidemiological studies might fail

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Family Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

Lp(a) lipoprotein and pre-beta1-lipoprotein in patients with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

Apolipoproteins (a), AI, and B and parental history in men with early onset ischaemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

Lipoprotein(a) as a risk predictor for cardiac mortality in patients with acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

Occlusive arterial thrombosis in cynomolgus monkeys with varying plasma concentrations of lipoprotein(a)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

Proteoglycans contribution to association of Lp(a) and LDL with smooth muscle cell extracellular matrix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900652-5

10.1016/S0002-9343(00)00652-5

7 January 2021

Identifiers

DOI

1 reference

release_i4kzbmopg5fyhjq6s4frmh5q5q

4 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/i4kzbmopg5fyhjq6s4frmh5q5q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference